June 30, 2020
Novo Nordisk Japan President Ole Moelskov Bech Novo Nordisk sees plenty of opportunities that would help it eventually achieve Japan sales of 100 billion yen as it gears up to push its new once-weekly GLP-1 agent Ozempic (semaglutide) and a...read more